Cambridge, United Kingdom

Louisa Jane Quegan

This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Paion UK Limited, Millennium Pharmaceuticals Limited. Active years: 2013-2025.

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Impington, GB (2013)
  • Cambridge, GB (2017 - 2021)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Louisa Jane Quegan: Innovator in Medicinal Chemistry

Introduction

Louisa Jane Quegan is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of short-acting benzodiazepine salts. With a total of six patents to her name, her work has had a considerable impact on the pharmaceutical industry.

Latest Patents

Among her latest patents is the invention related to short-acting benzodiazepine salts and their polymorphic forms. This invention focuses on besylate salts of a specific compound, detailing methods of preparing these salts and their applications as medicaments. The uses of these salts include sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes.

Career Highlights

Louisa has worked with notable companies such as Paion UK Limited and Millennium Pharmaceuticals Limited. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in the field of medicine.

Collaborations

Some of her coworkers include Gary Stuart Tilbrook and Anjali Pandey, who have collaborated with her on various projects throughout her career.

Conclusion

Louisa Jane Quegan's contributions to medicinal chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of important pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…